FDA Eyes End Of Year As Deadline For Inspection Procedure Overhaul
The reorganizational push at the agency comes in the wake of the infant formula crisis. Other FDA news is on manufacturing problems at an Eli Lilly plant, rules to trace foodborne illness outbreaks, and a Novartis breast cancer treatment TV ad.